Oral formulations of cytidine analogs and methods of use thereof

Details for Australian Patent Application No. 2009246926 (hide)

Owner Celgene Corporation

Inventors Etter, Jeffrey B.; Backstrom, Jay Thomas; Lai, Mei

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-A-2009246926

PCT Pub. Number WO2009/139888

Priority 61/157,875 05.03.09 US; 61/053,609 15.05.08 US; 61/201,145 05.12.08 US

Filing date 14 May 2009

Wipo publication date 19 November 2009

International Classifications

A61K 9/20 (2006.01) Medicinal preparations characterised by special physical form - Pills, lozenges or tablets

A61K 9/28 (2006.01) Medicinal preparations characterised by special physical form - Dragees

A61K 31/7068 (2006.01)

Event Publications

16 December 2010 PCT application entered the National Phase

  PCT publication WO2009/139888 Priority application(s): WO2009/139888

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009246928-Biologically active recombinant human Saposin C and PSAP

2009246925-Non-inflammatory gluten peptide analogues as biomarkers for celiac sprue